Over 400 million individuals worldwide, according to the World Health Organization (WHO), have diabetes, living each day on the precipice of health determined by the level of sugar in their bloodstream. The vigilance required to ensure that their levels are neither too high nor too low can often become all-encompassing. A circumstance that Lonny Stormo, co-founder and CEO of the Oak Park Heights, Minnesota-based startup, Pops, truly understands.
Lonny Stormo, Co-founder and CEO of Pops
Stormo brought his proficiency in electrical engineering and business to the medical device industry over three decades ago. He has served in various executive leadership roles during his thirty-year career at industry giant Medtronic, and even collaborated with NASA. Though his work at Medtronic was primarily focused on cardiovascular health, he developed a vested interest in diabetes care when, in his mid-thirties, Stormo was diagnosed with adult onset type 1 diabetes.
As an active member of his community and an avid runner, Stormo was often frustrated by the encumbrance that conventional blood sugar monitoring would have on his lifestyle. After fifteen years of observing the same testing and tracking regimen, this medical device industry veteran began to question whether there was a better way to do this.
How can it be with all the advances we were making in medicine, that I had been managing my diabetes the same exact way these years, with the same black zip-up bag holding a meter and test strips and a lancing tool that you had to assemble, says Stormo, describing the equipment that those with diabetes typically use to keep track of their daily blood sugar levels, The test kit was too big to carry around wherever I went. Besides, I was not comfortable taking everything out to run a test in front of everybody and often there would not be a table around for me to set things up on. It was all very inconvenient.
Stormo suggested that because of the inconvenience associated with this cumbersome approach, many with diabetes, as he often did, would just leave their test kits at home. Beyond seeing their blood sugar level results perhaps, a couple times a day while at home, many do not have any idea what their true status is. That is, until the next biannual medical exam when the HbA1C test that indicates the prior months blood sugar level average, is performed. By then, if the readings suggest their blood sugar concentration has been too high, any deterioration to their health that could result may have already taken place.
Poor self-monitoring of blood sugar levels over time is a leading cause of long-term health complications for those with diabetes complications that range from nerve damage, vision loss, kidney failure, heart attacks, stroke and lower limb amputation to death. According to the most recent report from the International Diabetes Foundation (IDF) citing data for 2017, approximately four million deaths globally were attributed to known cases of diabetes, thus placing it among the top ten causes of mortality worldwide (WHO 2018). Associated healthcare costs, in 2017 alone, amounted to $727 billion USD globally of which 48% was attributed to individuals living in the United States. Americans with diabetes spent on average $12,000 USD on health care in 2017, which is twice the cost incurred by those who live without diabetes (numbers taken from IDF 2017 report).
Stormo recognized that the struggles he faced managing his own care reflected the experience of millions of others in the US and is implicated in the high health care costs for those with diabetes. So, he decided to do something about it.
He leveraged his decades of experience and extensive network in the medical device field to gather a team of like-minded colleagues co-founders, Dan Davis, Pops current Security Officer and VP of R&D, and Curt Christensen, Pops VP of Operations with a mission to improve the lives of those with diabetes. Thus, in 2015, Pops Diabetes Care was launched by this team that understands what living with diabetes is like, and who are determined to make it easier for those with diabetes to control their blood sugar levels, therefore reducing their risk of expensive health complications.
Our vision is lowering the worlds A1c one person at a time, Stormo explains.
Their strategy involves addressing the reasons why many individuals do not adhere to regular testing. A Reality of Diabetes Care Survey reported by the Canadian-based Medical Education Network (Mednet) back in 2010, identified several of these reasons thus validating what those dealing with these challenges daily have been saying for years. These reasons, further characterized in subsequent studies, include forgetfulness, insufficient time for regular testing, not having all the things needed to test, unreliable meters, not wanting to carry around the equipment for the tests, pain and testing anxiety, inability to test discretely, lack of motivation, and even concerns regarding safe disposal of the used test strips and lances. A daunting list of deterrents that Stormo and his team were all too familiar with.
If we want people to manage their diabetes all the time and do it better, says Stormo, We have to give them a better experience. What we have done is reengineered that experience to make it easy for them to test their blood sugar less painfully, discretely, no assembly needed, anywhere, at any time, with non-invasive, non-judgmental virtual coaching.
Stormo and his team developed a portable test kit that can (doesnt have to) pop-on to the back of a smartphone to which it interfaces via wireless connection to a Pops virtual management care app.
I can now literally check my blood sugar anytime, anywhere while I am on the road for a run, something I could never do before, explains an enthusiastic Stormo, One time at a business competition, I was standing on stage and it was time to check my blood sugar levels. So right there in front of hundreds of people, I quickly pulled out my phone and discretely did a test. Simple. No fuss.
The Pops approach aligns with the current shift in individual behavior being observed across the healthcare landscape. Subject to a conventional system that does not always serve their best interests, patients are less passively resigned to receive services offered as is. Rather they are being more selective about their care and are actively pursuing alternatives that confer better outcomes.
This increasing demand for consumer-focused healthcare services is further bolstered by the recent acceleration in technological innovation. In an imperfect healthcare system, where many struggle to access appropriate care, it is not surprising that individuals are seeking solutions through advanced technologies that enhance the delivery of such care.
A 2017 report by consulting group, Deloitte Development LLC, indicates that over 70% of consumers in the US prioritize access thus are comfortable using virtual health platforms to manage their own care or coordinate with providers. According to Statista, 77% of US adults surveyed over a two-month period in 2018 were satisfied with their virtual care experience, confirming this trend.
People want to take healthcare into their own hands using technology, says Stormo, Previously, we were using technology to connect patients and doctors, sending information to the doctor then waiting for the doctor to respond with what to do, perhaps via a video console. Now people are managing their health directly using easy, convenient, smart technology. And living their lives. This is the next step virtual care people are empowered to self-manage their conditions.
Pops not only includes an integrated virtual care system they call Rebel, but also Mina, a 24/7, non-judgmental personal virtual coach. Rebel and Mina together provide non-invasive blood sugar-testing and monitoring along with basic analytics that inform guidance and support. In addition, everyone using the system is considered an owner controlling how and with whom, if anyone, their information is shared, whether its with friends, family and/or caregivers.
At Pops, we are enabling you to take care of yourself, to own your condition, to own your life, says Stormo, You have diabetes, but it does not define you. You are a person first and foremost.
Last year, Pops patented system received FDA clearance. Since then, they have established partnerships with healthcare plans and employers who have included Pops in their employee benefits offerings, promoting healthier employees, greater productivity at work, and an associated reduction in company healthcare costs. In the future, Stormo would like for everyone with diabetes to have access to Pops, regardless. For now, the system is not yet directly available to the consumer.
This purpose-driven company has been gaining attention across the country. Pops recently closed an oversubscribed Series A funding round of $6 million USD as a result of heightened investor interest. The round was led by 30Ventures, a healthcare and biotechnology venture capital firm based out of Madison, Wisconsin.
Also participating in this round was New York-based investment firm, Flying Point Industries and Revolutions Rise of the Rest Seed Fund, a Washington D.C.-based firm founded by AOL co-founder Steve Case that focuses on funding highly promising seed stage companies outside the startup hubs of Silicon Valley, New York City, and Boston.
In a recent press release, Stormo expressed his gratitude for the strong investor support, We are pleased that investors see this commercial growth as a sign that diabetes virtual care is making a difference for people with diabetes. The funds will be used to further the commercialization of Pops system.
Pops was also recently chosen to participate in the 2019 Winter Insurtech program run by globally renowned startup accelerator, Plug and Play.
Though grateful for the validation and support received this year, for Stormo, nothing comes close to the fullfilment he experienced that memorable day, when Pops received the first testimonial from the first person whose HbA1C levels were lowered by 1.5 points using the Pops system.
The first thing we see each day walking through the front doors is his framed photo the first person whose life we changed, says Stormo proudly, That is what our mission is all about!
For more information about Lonny Stormo and Pops, visit http://www.popsdiabetes.com.
REFERENCES:
https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death
http://www.mednet.ca/docs/pdf/HO10-005_E_with_WM.pdf
Josh Nelson, Bryan Sung, Sunil Venkataram, and Jennifer Moore, Transforming care delivery through virtual health, Deloitte, 2017.
Read more here:
Pops on the go virtual care system empowers those with diabetes to Own Their Life - Silicon Prairie News
- This 'itchy' symptom is an early sign of diabetes that people often miss; know more about it - The Times of India - February 7th, 2025
- Diabetes and obesity drugs fuel Eli Lilly profit in the final quarter of 2024 - ABC News - February 7th, 2025
- Incidence of type 2 diabetes and metabolic syndrome by Occupation 10-Year follow-up of the Gutenberg Health Study - BMC Public Health - February 7th, 2025
- Abbotts Above the Bias Film Reveals Misconceptions Can Impact Diabetes Care - MultiVu - February 7th, 2025
- Q&A: Diabetes care for the aging population in the digital age - Medical Xpress - February 7th, 2025
- The relationship between oxLDL, sLOX-1, PCSK9 and carotid intima-media thickness in patients with prediabetes and type 2 diabetes - Nature.com - February 7th, 2025
- Nanoparticle Therapy has Potential to Reprogram the Immune System in Type 1 Diabetes - Managed Healthcare Executive - February 7th, 2025
- Muscle quality index is correlated with insulin resistance and type 2 diabetes mellitus: a cross-sectional population-based study - BMC Public Health - February 7th, 2025
- Assessing type-2 diabetes risk based on the Indian diabetes risk score among adults aged 45 and above in India - Nature.com - February 7th, 2025
- Single-cell atlas of human pancreatic islet and acinar endothelial cells in health and diabetes - Nature.com - February 7th, 2025
- Sugary Drinks Fuel Millions of Diabetes and CVD Cases - Medscape - February 7th, 2025
- 1 in 5 UK adults estimated to have diabetes in new record high - Euronews - February 7th, 2025
- New, increasingly widely used diabetes medication may have additional health benefits for older adults - Medical Xpress - February 7th, 2025
- Patients using diabetes apps can miss critical alerts. Heres how to make sure youre getting them - Canon City Daily Record - February 7th, 2025
- Diabetes and obesity drugs fuel Eli Lilly profit in the final quarter of 2024 - News-Press Now - February 7th, 2025
- Does wearing a continuous glucose monitor help people without diabetes? We asked experts. - Popular Science - February 7th, 2025
- What is prediabetes and what can you do to stop it? - The Independent - February 7th, 2025
- Diabetes symptoms: 6 high blood sugar warning signs that show on hand and feet - India.com - February 7th, 2025
- The #1 Habit for Better Heart Health If You Have Diabetes, According to Experts - EatingWell - February 7th, 2025
- 'Fix Broken Food System!' Government Urged as Study Says 1 in 5 Brits Affected by Diabetes - Men's Health UK - February 7th, 2025
- World Diabetes Day 2024 - World Health Organization (WHO) - December 6th, 2024
- The WHO Global Diabetes Compact - December 6th, 2024
- Diabetes - World Health Organization (WHO) - December 6th, 2024
- Kumamoto University researchers discover groundbreaking antidiabetic compound - EurekAlert - December 6th, 2024
- Med's David Kaelber comments on GLP-1 agonists, which provide benefits like managing diabetes and weight loss - The Daily | Case Western Reserve... - December 6th, 2024
- Jordan Chiles Is On a Mission To Raise Awareness for Early Type 1 Diabetes Screening - Verywell Health - December 6th, 2024
- There's A Tasty Food That May Reduce Your Risk Of Developing Type 2 Diabetes, Study Shows - HuffPost - December 6th, 2024
- Empagliflozin Linked to Lower Risk of Diabetic Retinopathy Progression - Medpage Today - December 6th, 2024
- GLP-1 Medications Associated with Reduced Likelihood of Dementia Compared to Other Diabetic Meds - Epic Research - December 6th, 2024
- Sanders Slams Greed That Led to Surge in Obesity, Diabetes in US - The Well News - December 6th, 2024
- Eli Lilly to Expand Facility to Meet Demand for Diabetes, Obesity Treatments - The Wall Street Journal - December 6th, 2024
- New Study Teases Out Chocolate and Diabetes Connection - Medpage Today - December 6th, 2024
- Diabetes tool turned wellness trend: Is a glucose monitor right for you? - KARE11.com - December 6th, 2024
- Reporter doesnt have diabetes but wore a glucose monitor anyway. Here's what she learned - CNN - December 6th, 2024
- Lilly's Zepbound (tirzepatide) superior to Wegovy (semaglutide) in head-to-head trial showing an average weight loss of 20.2% vs. 13.7% - Investors |... - December 6th, 2024
- I dont have diabetes, but I wore a glucose monitor for six weeks. Heres what I learned about food (and anxiety) - CNN - December 6th, 2024
- Higher niacin levels linked to lower cardiovascular risk, but not in those with diabetes - Healio - December 6th, 2024
- This Type Of Chocolate Could Reduce Type 2 Diabetes Risk By 21% - NDTV - December 6th, 2024
- New Study Links Safer BPA Alternatives to Obesity, Diabetes, and Hormone Disruption - SciTechDaily - December 6th, 2024
- Turns Out Dark Chocolate Has a Health Benefit That's Shockingly GreatAnd Totally Unexpected - Well+Good - December 6th, 2024
- Global report on diabetes - World Health Organization (WHO) - October 22nd, 2024
- Ultra-processed food may be particularly harmful for people with diabetes, scientists warn - The Independent - October 22nd, 2024
- New drugs may be able to treat multiple problems beyond diabetes - The Straits Times - October 22nd, 2024
- Best Fruits for Diabetes (and What To Avoid) - Health Essentials - October 22nd, 2024
- Cutting Sugar May Reduce Your Diabetes, Stroke, and Depression Risk - Healthline - October 22nd, 2024
- Can Diabetes Care Teams Improve Patient Outcomes and Value? - Medscape - October 22nd, 2024
- Oral Semaglutide Reduces MACE Risk in People With Type 2 Diabetes and CVD - MD Magazine - October 22nd, 2024
- High expression of CNOT6L contributes to the negative development of type 2 diabetes - Nature.com - October 22nd, 2024
- Recent Advances and Therapeutic Benefits of Glucagon-Like Peptide-1 (GLP-1) Agonists in the Management of Type 2 Diabetes and Associated Metabolic... - October 22nd, 2024
- Dental teams could detect undiagnosed diabetes in more than one million people with new care pathway - Nature.com - October 22nd, 2024
- Groundbreaking Innovations in Diabetes Care: Highlights from the 2024 Diabetes Technology Meeting - Beyond Type 1 - October 22nd, 2024
- COVID-19 linked to type 2 diabetes onset in children - Medical Xpress - October 22nd, 2024
- The effect of adding pancreatin to standard otilinium bromide and simethicone treatment in type 2 diabetes mellitus patients with irritable bowel... - October 22nd, 2024
- Does microdosing Ozempic work? What experts are saying about the diabetes drug also used for weight loss - Medical Xpress - October 22nd, 2024
- The Link between GLP-1 Drugs and Diabetic Retinopathy Is Not So Clear | AAO 2024 - Managed Healthcare Executive - October 22nd, 2024
- The overexpression of human amylin in pancreatic cells facilitate the appearance of amylin aggregates in the kidney contributing to diabetic... - October 22nd, 2024
- RNAO releases updated guidelines for diabetic foot ulcer care - Benefits and Pensions Monitor - October 22nd, 2024
- COVID-19 raises the risk of type 2 diabetes in children, study reveals - News-Medical.Net - October 22nd, 2024
- Semaglutide: What impact does it really have on heart health? - Medical News Today - October 22nd, 2024
- Glucose monitors for diabetes have finally been funded but a chronic workforce shortage will limit the benefits - The Conversation - October 22nd, 2024
- Early vs Late Fast Window: Is One More Effective? - Medscape - September 13th, 2024
- Breakthrough T1D Walk to Cure Type 1 Diabetes - KATU - September 13th, 2024
- Foods That May Increase Kids' Risk of Type 1 Diabetes Revealed - Newsweek - September 13th, 2024
- Beds and Herts patients to be re-tested in diabetes results error - BBC.com - September 13th, 2024
- This common habit increases your diabetes risk by 50%; Heres how to fix it - The Economic Times - September 13th, 2024
- Elevated risk of pre-diabetes and diabetes in people with past history of COVID-19 in northeastern Nigeria - BMC Public Health - September 13th, 2024
- Study links bananas, oats and yoghurt to greater diabetes risk in susceptible children - The Guardian - September 13th, 2024
- Could the Norton research teams studying diabetes and Alzheimer's come up with a cure? - Courier Journal - September 13th, 2024
- Weight loss, better beta-cell function tied to long-term glycemic control with tirzepatide - Healio - September 13th, 2024
- Study finds weekly insulin injections as effective for diabetes as daily shots - UPI News - September 13th, 2024
- Ozempic, Wegovy, Rybelsus: Are we losing sight of overall health? Heres what the science says - The Conversation - September 13th, 2024
- With once-a-week dosing, insulin efsitora alfa delivers similar A1C reduction compared to daily insulin in adults with type 1 diabetes - PR Newswire - September 13th, 2024
- Dining with Diabetes workshops offered - The Courier-Express - September 13th, 2024
- Researchers uncover connection between two common diabetes drugs with implications for foot ulcer healing - News-Medical.Net - September 13th, 2024
- The menopause can increase your likelihood of developing heart disease, type 2 diabetes and hypertension but exercise can help lower risk - The... - September 13th, 2024
- Artificial pancreas shows promise in people with type 1 diabetes on kidney dialysis - MSN - September 13th, 2024
- How an Indian executive battled flesh-eating disease and diabetes, and won - South China Morning Post - September 13th, 2024
- India brings early Diabetic Retinopathy detection to the last mile with Artificial Intelligence - PR Newswire - September 13th, 2024
- Why this diabetes drug may be the answer to NASA search for radiation protection - Texas Public Radio - September 13th, 2024
- The National Association of Chain Drug Stores and the American Diabetes Association Promote Nutrition Security and its Role in Preventing and Managing... - September 13th, 2024